Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 Feb;8(1):60-6.
doi: 10.1007/s11894-006-0065-x.

Management of recurrent viral hepatitis B and C after liver transplantation

Affiliations
Review

Management of recurrent viral hepatitis B and C after liver transplantation

Marzia Montalbano et al. Curr Gastroenterol Rep. 2006 Feb.

Abstract

Liver transplant teams are often faced with the challenges of managing viral recurrence after liver transplantation. Hepatitis C virus (HCV) remains the most challenging viral disease in the transplant community. Strategies to prevent and delay viral recurrence have slowly developed over the past 5 years. Hepatitis B virus (HBV), previously a contraindication for liver transplantation due to recurrence and cholestasis with allograft failure, is now one of the more favorable indications for liver transplantation as a result of current therapeutic options. This review investigates the up-to-date information on treatment outcomes for HCV and HBV in the period following liver transplant.

PubMed Disclaimer

References

    1. Transplantation. 2003 Feb 15;75(3 Suppl):S49-53 - PubMed
    1. Clin Transplant. 2000;14 Suppl 2:14-9 - PubMed
    1. Semin Liver Dis. 2004;24 Suppl 1:55-62 - PubMed
    1. J Gastroenterol Hepatol. 2002 Feb;17 Suppl:S125-45 - PubMed
    1. Transplant Proc. 2003 Aug;35(5):1850-1 - PubMed

MeSH terms

Substances

LinkOut - more resources